Mostrando 7 resultados de: 7
Filtros aplicados
Publisher
International Journal of Pharmaceutics(2)
Applied Sciences (Switzerland)(1)
Colloids and Surfaces B: Biointerfaces(1)
Epilepsia Open(1)
Nanomaterials(1)
Área temáticas
Farmacología y terapéutica(6)
Enfermedades(3)
Medicina y salud(3)
Cirugía y especialidades médicas afines(2)
Fisiología y materias afines(2)
Área de conocimiento
Farmacología(3)
Biomateriales(1)
Biomedicina(1)
Ciencia de materiales(1)
Nanopartícula(1)
Origen
scopus(7)
Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges
ReviewAbstract: Epilepsy is the second most prevalent neurological disease worldwide. It is mainly characterized byPalabras claves:Epilepsy, lipid nanoparticles, Nanomedicine, nanotechnology, neurodegenerative diseases, Polymeric nanoparticlesAutores:Antoni Camins, Bonilla L., Cano A., Espina M., Esteruelas G., Ettcheto M., García M.L., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusCell penetrating peptides-functionalized Licochalcone-A-loaded PLGA nanoparticles for ocular inflammatory diseases: Evaluation of in vitro anti-proliferative effects, stabilization by freeze-drying and characterization of an in-situ forming gel
ArticleAbstract: Licochalcone-A (Lico-A) PLGA NPs functionalized with cell penetrating peptides B6 and Tet-1 are propPalabras claves:cell penetrating peptide, Freeze-drying, In-situ forming gel, Licochalcone-A, Ocular anti-inflammatory, PLGA nanoparticlesAutores:Antoni Camins, Espina M., Fonseca J., Galindo-Camacho R.M., García M.L., Gómara M.J., Haro I., Martins-Gomes C., Silva A.M., Souto E.M.B.Fuentes:scopusArticle dexibuprofen biodegradable nanoparticles: One step closer towards a better ocular interaction study
ArticleAbstract: Ocular inflammation is one of the most prevalent diseases in ophthalmology, which can affect variousPalabras claves:Dexibuprofen, Drug delivery system, Nanoparticles, PLGAAutores:Alsafi Z., Antoni Camins, Calpena A.C., Cano A., Espina M., Esteruelas G., Ettcheto M., García M.L., Muñoz M., Ortiz A., Prat J., Pujol M., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopusPEGylated PLGA nanospheres optimized by design of experiments for ocular administration of dexibuprofen-in vitro, ex vivo and in vivo characterization
ArticleAbstract: Dexibuprofen-loaded PEGylated PLGA nanospheres have been developed to improve the biopharmaceuticalPalabras claves:Dexibuprofen, drug delivery, inflammation, Nanospheres, PEG, PLGAAutores:Antoni Camins, Calpena A.C., Cano A., Egea M.A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Silva A.M., Souto E.M.B.Fuentes:scopusIn vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration
ArticleAbstract: Pranoprofen (PF) is a NSAID considered as a safe anti-inflammatory treatment for strabismus and/or cPalabras claves:Anti-inflammatory efficacy, Corneal permeation, Cytotoxicity cell, Nanoparticles, Poly (lactic/glycolic) acid (PLGA), PranoprofenAutores:Abrego G., Alvarado H., Calpena A.C., Cristina Cañadas, García M.L., Silva A.M., Souto E.M.B.Fuentes:scopusLipid Nanoparticles for the Posterior Eye Segment
ReviewAbstract: This review highlights the application of lipid nanoparticles (Solid Lipid Nanoparticles, NanostructPalabras claves:Drug transport, lipid nanoparticles, NLC, Ocular barriers, Ocular drug delivery, Posterior segment, SLNAutores:Antoni Camins, Bonilla L., Cano A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Severino P., Souto E.M.B.Fuentes:scopusSurface functionalization of plga nanoparticles to increase transport across the bbb for alzheimer’s disease
ReviewAbstract: Alzheimer’s disease (AD) is a chronic neurodegenerative disorder that accounts for about 60% of allPalabras claves:Alzheimer’s disease, blood-brain barrier, Brain delivery, Functionalized PLGA nanoparticlesAutores:Amo L.D., Antoni Camins, Cano A., Espina M., Ettcheto M., García M.L., Sanchez-Lopez E., Souto E.M.B.Fuentes:scopus